Skip to content
Find a Provider
Richard Dunne, M.D., M.S.

Richard Dunne, M.D., M.S.

Hematology & Oncology , Cancer

5 out of 5 stars
283 Ratings
26 Comments
UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients

Contact

Appointment (585) 275-5823
Fax (585) 273-1051

About Me

When a patient is diagnosed with cancer, he or she is faced with a lot of questions and uncertainty of what the future holds. My philosophy is to provide as much information as possible so that patients can make the best decisions for themselves and their families and so that together we can face an...
When a patient is diagnosed with cancer, he or she is faced with a lot of questions and uncertainty of what the future holds. My philosophy is to provide as much information as possible so that patients can make the best decisions for themselves and their families and so that together we can face any fears or worries head on.

I chose this field because my hope is to make the lives of cancer patients better – whether it is through direct patient care or my research, which focuses on pancreatobiliary cancers, as well as weight loss and muscle wasting related to cancer.

In addition to being passionate about cancer care, I have many interests outside of work that I enjoy sharing with my patients such as sports, travel and music.

Conditions I Treat

- Esophageal cancer
- Gastric cancer
- Liver cancer
- Pancreatic cancer
- Colorectal cancer
- Anal cancer

Faculty Appointments

Associate Professor - Department of Medicine, Hematology/Oncology (SMD)

Credentials

Residency & Fellowship

Fellowship, Research, University of Rochester Medical Center. 2016 - 2019

Fellowship, Hematology & Oncology, University of Rochester Medical Center. 2013 - 2015

Residency, Internal Medicine, University of Rochester Medical Center. 2010 - 2012

Internship, Internal Medicine, University of Rochester Medical Center. 2009 - 2010

Education

MS | University of Rochester. 2021

MD | SUNY Downstate Health Sciences University - College of Medicine. 2009

Awards

Cancer Grand Challenges: Understand and Reverse Cachexia. 2022 - 2027

Solid Tumor Faculty Leader in clinical trial accrual. 2020 - 2021

CTSI KL2 Career Development Award. 2019 - 2021

Department of Medicine Research Pilot Grant Award. 2017 - 2018

NIH R25 Fellowship Training Program in Cancer Control. 2016 - 2019

Wilmot Foundation for Cancer Research Fellowship Award. 2015 - 2018

Research

Clinical Trials

An Open-label Phase 1 Study to Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Lead Researcher: Richard F Dunne

The main purpose of this research study is to determine the maximum tolerable dose (MTD) of SX-682 in combination with nivolumab in patients with metastatic pancreatic ductal adenocarcinoma who have completed at least 16 weeks of first line chemother...

Publications

Journal Articles

The Rochester Protocol for Living Donor Liver Transplantation of Unresectable Colorectal Liver Metastasis: A 5-Year Report on Selection, Approval, and Outcomes.

Byrne MM, Chávez-Villa M, Ruffolo LI, Loria A, Endo Y, Niewiemski A, Jimenez-Soto C, Melaragno JI, Gopal R, Farooq PD, Dunne RF, Pineda-Solis K, Nair A, Orloff M, Tomiyama K, Hernandez-Alejandro R

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.. 2024 September 25 Epub 09/25/2024.

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.

Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2024 September 2132 (10):677. Epub 09/21/2024.

Ponsegromab for the Treatment of Cancer Cachexia.

Groarke JD, Crawford J, Collins SM, Lubaczewski S, Roeland EJ, Naito T, Hendifar AE, Fallon M, Takayama K, Asmis T, Dunne RF, Karahanoglu I, Northcott CA, Harrington MA, Rossulek M, Qiu R, Saxena AR

The New England journal of medicine.. 2024 September 14 Epub 09/14/2024.

MRI Predicts Residual Disease and Outcomes in Watch-and-Wait Patients with Rectal Cancer.

Williams H, Omer DM, Thompson HM, Lin ST, Verheij FS, Miranda J, Yuval JB, Buckley J, Marco MR, Qin LX, Dombroski DA, Kedar R, Oto A, Korngold E, Veniero JC, Gandhi S, Krishnaraj A, Jagtiani M, Ohanian K, Vu D, Hope TA, Lee S, Wasnik AP, Madhuripan N, Gollub MJ, Garcia-Aguilar J,

Radiology.. 2024 September 312 (3):e232748. Epub 1900 01 01.

Baseline MRI predictors of successful organ preservation in the Organ Preservation in Rectal Adenocarcinoma (OPRA) trial.

Williams H, Yuval JB, Verheij FS, Miranda J, Lin ST, Omer DM, Qin LX, Gollub MJ, Kim TH, Garcia-Aguilar J,

The British journal of surgery.. 2024 August 30111 (9)Epub 1900 01 01.

The mortality burden of cachexia or weight loss in patients with colorectal or pancreatic cancer: A systematic literature review.

Dunne RF, Crawford J, Smoyer KE, McRae TD, Rossulek MI, Revkin JH, Tarasenko LC, Bonomi PD

Journal of cachexia, sarcopenia and muscle.. 2024 August 2 Epub 08/02/2024.

Mortality burden of pre-treatment weight loss in patients with non-small-cell lung cancer: A systematic literature review and meta-analysis.

Bonomi PD, Crawford J, Dunne RF, Roeland EJ, Smoyer KE, Siddiqui MK, McRae TD, Rossulek MI, Revkin JH, Tarasenko LC

Journal of cachexia, sarcopenia and muscle.. 2024 August 15 (4):1226-1239. Epub 04/22/2024.

Nutritional impairment, psychological health and quality of life among older adults with advanced cancer: A secondary analysis of a randomized clinical trial.

Singhal S, Wang Y, Qin Z, Peterson DR, Dunne RF, Culakova E, Hopkins JO, Melnyk N, Onitilo A, Targia V, Mohile S, Loh KP

Cancer medicine. 2024 June 13 (12):e7348. Epub 1900 01 01.

Prognostic implications of tumor histology and microenvironment in surgically resected intrahepatic cholangiocarcinoma: a single institutional experience.

Chen IY, Dunne RF, Liao X

Virchows Archiv : an international journal of pathology.. 2024 March 19 Epub 03/19/2024.

Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.

Kleckner IR, Manuweera T, Lin PJ, Chung KH, Kleckner AS, Gewandter JS, Culakova E, Tivarus ME, Dunne RF, Loh KP, Mohile NA, Kesler SR, Mustian KM

Research square.. 2024 March 13 Epub 03/13/2024.

Endoscopic Predictors of Residual Tumor After Total Neoadjuvant Therapy: A Post Hoc Analysis From the Organ Preservation in Rectal Adenocarcinoma Trial.

Williams H, Thompson HM, Lin ST, Verheij FS, Omer DM, Qin LX, Garcia-Aguilar J,

Diseases of the colon and rectum.. 2024 March 167 (3):369-376. Epub 11/20/2023.

Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial.

Verheij FS, Omer DM, Williams H, Lin ST, Qin LX, Buckley JT, Thompson HM, Yuval JB, Kim JK, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Guillem JG, Temple L, Goodman KA, Segal NH, Cercek A, Yaeger R, Nash GM, Widmar M, Wei IH, Pappou EP, Weiser MR, Paty PB, Smith JJ, Wu AJ, Gollub MJ, Saltz LB, Garcia-Aguilar J

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2024 February 1042 (5):500-506. Epub 10/26/2023.

SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma: Clinicopathologic and immunohistochemical study.

Chen IY, Ettel MG, Bell PD, Huber AR, Findeis-Hosey JJ, Wang W, Hezel AF, Dunne RF, Drage MG, Agostini-Vulaj D

Human pathology.. 2024 February 144 :40-45. Epub 02/01/2024.

Cachexia: A systemic consequence of progressive, unresolved disease.

Ferrer M, Anthony TG, Ayres JS, Biffi G, Brown JC, Caan BJ, Cespedes Feliciano EM, Coll AP, Dunne RF, Goncalves MD, Grethlein J, Heymsfield SB, Hui S, Jamal-Hanjani M, Lam JM, Lewis DY, McCandlish D, Mustian KM, O'Rahilly S, Perrimon N, White EP, Janowitz T

Cell.. 2023 April 27186 (9):1824-1845. Epub 1900 01 01.

A Novel Use for Pelvic MRI Scans to Estimate Lean Body Mass and Screen for Sarcopenia in Patients With Rectal Cancer.

Melucci AD, Lynch OF, Loria A, Mustian KM, Dunne RF, Temple LK, Fleming FJ

Diseases of the colon and rectum.. 2023 March 166 (3):e122-e126. Epub 12/22/2022.

Spatially Resolved Single-Cell Assessment of Pancreatic Cancer Expression Subtypes Reveals Co-expressor Phenotypes and Extensive Intratumoral Heterogeneity.

Williams HL, Dias Costa A, Zhang J, Raghavan S, Winter PS, Kapner KS, Ginebaugh SP, Väyrynen SA, Väyrynen JP, Yuan C, Navia AW, Wang J, Yang A, Bosse TL, Kalekar RL, Lowder KE, Lau MC, Elganainy D, Morales-Oyarvide V, Rubinson DA, Singh H, Perez K, Cleary JM, Clancy TE, Wang J, Mancias JD, Brais LK, Hill ER, Kozak MM, Linehan DC, Dunne RF, Chang DT, Koong AC, Hezel AF, Hahn WC, Shalek AK, Aguirre AJ, Nowak JA, Wolpin BM

Cancer research.. 2023 February 383 (3):441-455. Epub 1900 01 01.

Low Preoperative Serum Creatinine is Common and Associated With Poor Outcomes After Nonemergent Inpatient Surgery.

Loria A, Glance LG, Melucci AD, Boodry C, Justiniano CF, Dunne RF, Mustian KM, Becerra AZ, Jusko TA, Temple LK, Fleming FJ

Annals of surgery.. 2023 February 1277 (2):246-251. Epub 11/28/2022.

Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.

Lin PJ, Altman BJ, Gilmore NJ, Loh KP, Dunne RF, Bautista J, Fung C, Janelsins MC, Peppone LJ, Melnik MK, Gococo KO, Messino MJ, Mustian KM

Journal of the National Comprehensive Cancer Network : JNCCN.. 2023 February 21 (2):153-162.e2. Epub 1900 01 01.

Neoadjuvant Chemotherapy Is Associated with Altered Immune Cell Infiltration and an Anti-Tumorigenic Microenvironment in Resected Pancreatic Cancer.

Dias Costa A, Väyrynen SA, Chawla A, Zhang J, Väyrynen JP, Lau MC, Williams HL, Yuan C, Morales-Oyarvide V, Elganainy D, Singh H, Cleary JM, Perez K, Ng K, Freed-Pastor W, Mancias JD, Dougan SK, Wang J, Rubinson DA, Dunne RF, Kozak MM, Brais L, Reilly E, Clancy T, Linehan DC, Chang DT, Hezel AF, Koong AC, Aguirre A, Wolpin BM, Nowak JA

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2022 December 128 (23):5167-5179. Epub 1900 01 01.

Communication About Fall Risk in Community Oncology Practice: The Role of Geriatric Assessment.

Jensen-Battaglia M, Lei L, Xu H, Loh KP, Wells M, Tylock R, Ramsdale E, Kleckner AS, Mustian KM, Dunne RF, Kehoe L, Bearden J, Burnette BL, Whitehead M, Mohile SG, Wildes TM

JCO oncology practice.. 2022 October 18 (10):e1630-e1640. Epub 08/19/2022.

The Interplay Among Pancreatic Cancer, Cachexia, Body Composition, and Diabetes.

Dunne RF, Roeland EJ

Hematology/oncology clinics of North America.. 2022 October 36 (5):897-910. Epub 09/23/2022.

Immunologic Strategies in Pancreatic Cancer: Making Tumors .

Ullman NA, Burchard PR, Dunne RF, Linehan DC

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 August 2040 (24):2789-2805. Epub 07/15/2022.

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.

Garcia-Aguilar J, Patil S, Gollub MJ, Kim JK, Yuval JB, Thompson HM, Verheij FS, Omer DM, Lee M, Dunne RF, Marcet J, Cataldo P, Polite B, Herzig DO, Liska D, Oommen S, Friel CM, Ternent C, Coveler AL, Hunt S, Gregory A, Varma MG, Bello BL, Carmichael JC, Krauss J, Gleisner A, Paty PB, Weiser MR, Nash GM, Pappou E, Guillem JG, Temple L, Wei IH, Widmar M, Lin S, Segal NH, Cercek A, Yaeger R, Smith JJ, Goodman KA, Wu AJ, Saltz LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2022 August 1040 (23):2546-2556. Epub 04/28/2022.

Addressing unmet needs for people with cancer cachexia: recommendations from a multistakeholder workshop.

Garcia JM, Dunne RF, Santiago K, Martin L, Birnbaum MJ, Crawford J, Hendifar AE, Kochanczyk M, Moravek C, Piccinin D, Picozzi V, Roeland EJ, Selig WKD, Zimmers TA

Journal of cachexia, sarcopenia and muscle.. 2022 April 13 (2):1418-1425. Epub 02/26/2022.

Association of Oncologist-Patient Communication With Functional Status and Physical Performance in Older Adults: A Secondary Analysis of a Cluster Randomized Clinical Trial.

Jensen-Battaglia M, Lei L, Xu H, Kehoe L, Patil A, Loh KP, Ramsdale E, Magnuson A, Kleckner AS, Wildes TM, Lin PJ, Mustian KM, Giri G, Whitehead M, Bearden J, Burnette BL, Geer J, Mohile SG, Dunne RF

JAMA network open.. 2022 March 15 (3):e223039. Epub 03/01/2022.

Using Geriatric Assessment to Guide Conversations Regarding Comorbidities Among Older Patients With Advanced Cancer.

Kleckner AS, Wells M, Kehoe LA, Gilmore NJ, Xu H, Magnuson A, Dunne RF, Jensen-Battaglia M, Mohamed MR, O'Rourke MA, Vogelzang NJ, Dib EG, Peppone LJ, Mohile SG

JCO oncology practice.. 2022 January 18 (1):e9-e19. Epub 07/06/2021.

Time-restricted Eating to Address Cancer-related Fatigue among Cancer Survivors: A Single-arm Pilot Study.

Kleckner AS, Altman BJ, Reschke JE, Kleckner IR, Culakova E, Dunne RF, Mustian KM, Peppone LJ

Journal of integrative oncology.. 2022 11 (5)Epub 05/30/2022.

Evaluation of geriatric assessment and management on the toxic effects of cancer treatment (GAP70+): a cluster-randomised study.

Mohile SG, Mohamed MR, Xu H, Culakova E, Loh KP, Magnuson A, Flannery MA, Obrecht S, Gilmore N, Ramsdale E, Dunne RF, Wildes T, Plumb S, Patil A, Wells M, Lowenstein L, Janelsins M, Mustian K, Hopkins JO, Berenberg J, Anthony N, Dale W

Lancet.. 2021 November 20398 (10314):1894-1904. Epub 11/03/2021.

Prevalence of and factors associated with treatment modification at first cycle in older adults with advanced cancer receiving palliative treatment.

Mohamed MR, Kyi K, Mohile SG, Xu H, Culakova E, Loh KP, Flannery M, Obrecht S, Ramsdale E, Patil A, Dunne RF, DiGiovanni G, Hezel A, Burnette B, Desai N, Giguere J, Magnuson A

Journal of geriatric oncology.. 2021 November 12 (8):1208-1213. Epub 07/14/2021.

Sarcopenia in the Older Adult With Cancer.

Williams GR, Dunne RF, Giri S, Shachar SS, Caan BJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 July 139 (19):2068-2078. Epub 05/27/2021.

Developing and adapting a mobile health exercise intervention for older patients with myeloid neoplasms: A qualitative study.

Loh KP, Sanapala C, Di Giovanni G, Klepin HD, Janelsins M, Schnall R, Culakova E, Vertino P, Susiarjo M, Mendler JH, Liesveld JL, Lin PJ, Dunne RF, Kleckner I, Mustian K, Mohile SG

Journal of geriatric oncology.. 2021 July 12 (6):909-914. Epub 03/04/2021.

From bench to bedside: updates in basic science, translational and clinical research on muscle fatigue in cancer cachexia.

Jackson KM, Cole CL, Dunne RF

Current opinion in clinical nutrition and metabolic care.. 2021 May 124 (3):216-222. Epub 1900 01 01.

Composition, Spatial Characteristics, and Prognostic Significance of Myeloid Cell Infiltration in Pancreatic Cancer.

Väyrynen SA, Zhang J, Yuan C, Väyrynen JP, Dias Costa A, Williams H, Morales-Oyarvide V, Lau MC, Rubinson DA, Dunne RF, Kozak MM, Wang W, Agostini-Vulaj D, Drage MG, Brais LK, Reilly E, Rahma OE, Clancy TE, Wang J, Linehan DC, Aguirre A, Fuchs CS, Coussens LM, Chang DT, Koong AC, Hezel AF, Ogino S, Nowak JA, Wolpin BM

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2021 February 1527 (4):1069-1081. Epub 12/01/2020.

The Impact of Early Referrals to Dietitians for Patients With Esophagogastric Cancer.

Roeland EJ, Dunne RF

Journal of the National Comprehensive Cancer Network : JNCCN.. 2021 February 219 (2):235-238. Epub 02/02/2021.

Excess Body Weight and Cancer-Related Fatigue, Systemic Inflammation, and Serum Lipids in Breast Cancer Survivors.

Inglis JE, Kleckner AS, Lin PJ, Gilmore NJ, Culakova E, VanderWoude AC, Mustian KM, Fernandez ID, Dunne RF, Deutsch J, Peppone LJ

Nutrition and cancer.. 2021 73 (9):1676-1686. Epub 08/19/2020.

Older adults with cancer and their caregivers - current landscape and future directions for clinical care.

Kadambi S, Loh KP, Dunne R, Magnuson A, Maggiore R, Zittel J, Flannery M, Inglis J, Gilmore N, Mohamed M, Ramsdale E, Mohile S

Nature reviews. Clinical oncology.. 2020 December 17 (12):742-755. Epub 09/02/2020.

Adjuvant Chemotherapy Use in Patients With Locally Advanced Rectal Cancer: A Single-Institution Experience.

Li F, Nielsen G, Baran A, Hu J, Wallace D, Preslar M, Fleming F, Temple L, Dunne RF, Noel M, Hezel AF, Tejani MA

Clinical colorectal cancer.. 2020 September 19 (3):e124-e128. Epub 04/14/2020.

Insulin-Like Growth Factor-1 Receptor Expression and Disease Recurrence and Survival in Patients with Resected Pancreatic Ductal Adenocarcinoma.

Du C, da Silva A, Morales-Oyarvide V, Dias Costa A, Kozak MM, Dunne RF, Rubinson DA, Perez K, Masugi Y, Hamada T, Brais LK, Yuan C, Babic A, Ducar MD, Thorner AR, Aguirre A, Kulke MH, Ng K, Clancy TE, Findeis-Hosey JJ, Chang DT, Hornick JL, Fuchs CS, Ogino S, Koong AC, Hezel AF, Wolpin BM, Nowak JA

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2020 August 29 (8):1586-1595. Epub 05/28/2020.

Incidence and Significance of GATA3 Positivity in Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma.

Gonzalez RS, Ramesh MK, Yang Q, Findeis-Hosey JJ, Zhou Z, Cates JMM, Dunne RF, Bratton LE, Agostini-Vulaj D

Applied immunohistochemistry & molecular morphology : AIMM. 2020 July 28 (6):460-463. Epub 1900 01 01.

Endocrine-Exocrine Signaling Drives Obesity-Associated Pancreatic Ductal Adenocarcinoma.

Chung KM, Singh J, Lawres L, Dorans KJ, Garcia C, Burkhardt DB, Robbins R, Bhutkar A, Cardone R, Zhao X, Babic A, Vayrynen SA, Dias Costa A, Nowak JA, Chang DT, Dunne RF, Hezel AF, Koong AC, Wilhelm JJ, Bellin MD, Nylander V, Gloyn AL, McCarthy MI, Kibbey RG, Krishnaswamy S, Wolpin BM, Jacks T, Fuchs CS, Muzumdar MD

Cell.. 2020 May 14181 (4):832-847.e18. Epub 04/17/2020.

Hepatocellular carcinoma in older adults: A comprehensive review by Young International Society of Geriatric Oncology.

Dotan E, Dua D, Rodriquenz MG, Okonji D, Moffat GT, Dunne RF, Caird S, Liposits G, Arora SP

Journal of geriatric oncology.. 2020 May 11 (4):557-565. Epub 11/06/2019.

Postdiagnosis Loss of Skeletal Muscle, but Not Adipose Tissue, Is Associated with Shorter Survival of Patients with Advanced Pancreatic Cancer.

Babic A, Rosenthal MH, Bamlet WR, Takahashi N, Sugimoto M, Danai LV, Morales-Oyarvide V, Khalaf N, Dunne RF, Brais LK, Welch MW, Zellers CL, Dennis C, Rifai N, Prado CM, Caan B, Sundaresan TK, Meyerhardt JA, Kulke MH, Clish CB, Ng K, Vander Heiden MG, Petersen GM, Wolpin BM

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2019 December 28 (12):2062-2069. Epub 09/18/2019.

Cachexia and Sarcopenia in Older Adults with Cancer: A Comprehensive Review.

Mohile SG, Mustian KM, Jatoi A, Williams GR, Loh KP, Dunne RF

Cancers.. 2019 November 2511 (12)Epub 11/25/2019.

Integrating Assessment of Sarcopenia into Decision-making for Allogeneic Hematopoietic Cell Transplantation: Ready for Prime Time?

Loh KP, Dunne RF, Friedberg JW, Mohile SG

Journal of the National Cancer Institute.. 2019 August 1111 (8):757-759. Epub 1900 01 01.

ARID1A, a SWI/SNF subunit, is critical to acinar cell homeostasis and regeneration and is a barrier to transformation and epithelial-mesenchymal transition in the pancreas.

Wang W, Friedland SC, Guo B, O'Dell MR, Alexander WB, Whitney-Miller CL, Agostini-Vulaj D, Huber AR, Myers JR, Ashton JM, Dunne RF, Steiner LA, Hezel AF

Gut.. 2019 July 68 (7):1245-1258. Epub 09/18/2018.

Characterizing cancer cachexia in the geriatric oncology population.

Dunne RF, Roussel B, Culakova E, Pandya C, Fleming FJ, Hensley B, Magnuson AM, Loh KP, Gilles M, Ramsdale E, Maggiore RJ, Jatoi A, Mustian KM, Dale W, Mohile SG

Journal of geriatric oncology.. 2019 May 10 (3):415-419. Epub 09/05/2018.

Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.

Loh KP, Kleckner IR, Lin PJ, Mohile SG, Canin BE, Flannery MA, Fung C, Dunne RF, Bautista J, Culakova E, Kleckner AS, Peppone LJ, Janelsins M, McHugh C, Conlin A, Cho JK, Kasbari S, Esparaz BT, Kuebler JP, Mustian KM

Journal of the American Geriatrics Society.. 2019 May 67 (5):1005-1011. Epub 1900 01 01.

Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer.

Yurgelun MB, Chittenden AB, Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Qian ZR, Welch MW, Brais LK, Da Silva A, Bui JL, Yuan C, Li T, Li W, Masuda A, Gu M, Bullock AJ, Chang DT, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar MD, Wollison BM, Khalaf N, Perez K, Syngal S, Aguirre AJ, Hahn WC, Meyerson ML, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Nowak JA, Wolpin BM

Genetics in medicine : official journal of the American College of Medical Genetics.. 2019 January 21 (1):213-223. Epub 07/02/2018.

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

Schaffer K, Panneerselvam N, Loh KP, Herrmann R, Kleckner IR, Dunne RF, Lin PJ, Heckler CE, Gerbino N, Bruckner LB, Storozynsky E, Ky B, Baran A, Mohile SG, Mustian KM, Fung C

Journal of the National Comprehensive Cancer Network : JNCCN.. 2019 January 17 (1):57-63. Epub 1900 01 01.

Beyond microsatellite testing: assessment of tumor mutational burden identifies subsets of colorectal cancer who may respond to immune checkpoint inhibition.

Fabrizio DA, George TJ, Dunne RF, Frampton G, Sun J, Gowen K, Kennedy M, Greenbowe J, Schrock AB, Hezel AF, Ross JS, Stephens PJ, Ali SM, Miller VA, Fakih M, Klempner SJ

Journal of gastrointestinal oncology.. 2018 August 9 (4):610-617. Epub 1900 01 01.

Association of Alterations in Main Driver Genes With Outcomes of Patients With Resected Pancreatic Ductal Adenocarcinoma.

Qian ZR, Rubinson DA, Nowak JA, Morales-Oyarvide V, Dunne RF, Kozak MM, Welch MW, Brais LK, Da Silva A, Li T, Li W, Masuda A, Yang J, Shi Y, Gu M, Masugi Y, Bui J, Zellers CL, Yuan C, Babic A, Khalaf N, Aguirre A, Ng K, Miksad RA, Bullock AJ, Chang DT, Tseng JF, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Thorner AR, Ducar M, Wollison B, Laing A, Hahn WC, Meyerson M, Fuchs CS, Ogino S, Hornick JL, Hezel AF, Koong AC, Wolpin BM

JAMA oncology.. 2018 March 84 (3):e173420. Epub 03/08/2018.

Exercise for Toxicity Management in Cancer-A Narrative Review.

Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM

Oncology & hematology review.. 2018 14 (1):28-37. Epub 02/15/2018.

The Role of Systemic Inflammation in Cancer-Associated Muscle Wasting and Rationale for Exercise as a Therapeutic Intervention.

Cole CL, Kleckner IR, Jatoi A, Schwarz EM, Dunne RF

JCSM clinical reports.. 2018 3 (2)Epub 1900 01 01.

Lymph node metastases in resected pancreatic ductal adenocarcinoma: predictors of disease recurrence and survival.

Morales-Oyarvide V, Rubinson DA, Dunne RF, Kozak MM, Bui JL, Yuan C, Qian ZR, Babic A, Da Silva A, Nowak JA, Khalaf N, Brais LK, Welch MW, Zellers CL, Ng K, Chang DT, Miksad RA, Bullock AJ, Tseng JF, Swanson RS, Clancy TE, Linehan DC, Findeis-Hosey JJ, Doyle LA, Hornick JL, Ogino S, Fuchs CS, Hezel AF, Koong AC, Wolpin BM

British journal of cancer.. 2017 December 5117 (12):1874-1882. Epub 10/05/2017.

Research priorities in cancer cachexia: The University of Rochester Cancer Center NCI Community Oncology Research Program Research Base Symposium on Cancer Cachexia and Sarcopenia.

Dunne RF, Mustian KM, Garcia JM, Dale W, Hayward R, Roussel B, Buschmann MM, Caan BJ, Cole CL, Fleming FJ, Chakkalakal JV, Linehan DC, Hezel AF, Mohile SG

Current opinion in supportive and palliative care.. 2017 December 11 (4):278-286. Epub 1900 01 01.

Down-regulation of cytoplasmic PLZF correlates with high tumor grade and tumor aggression in non-small cell lung carcinoma.

Xiao GQ, Li F, Findeis-Hosey J, Hyrien O, Unger PD, Xiao L, Dunne R, Kim ES, Yang Q, McMahon L, Burstein DE

Human pathology.. 2015 November 46 (11):1607-15. Epub 07/08/2015.

Genetics and Biology of Pancreatic Ductal Adenocarcinoma.

Dunne RF, Hezel AF

Hematology/oncology clinics of North America.. 2015 August 29 (4):595-608. Epub 06/10/2015.

A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy.

Dunne RF, Sahasrabudhe DM, Messing EM, Jean-Gilles J, Fung C

Rare tumors.. 2014 January 236 (1):5268. Epub 03/18/2014.

Diabetes mellitus is associated with the presence of metastatic spread at disease presentation in hepatocellular carcinoma.

Connolly GC, Safadjou S, Chen R, Nduaguba A, Dunne R, Khorana AA, Hezel AF

Cancer investigation.. 2012 December 30 (10):698-702. Epub 10/16/2012.

Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity.

Zhao X, Jankovic V, Gural A, Huang G, Pardanani A, Menendez S, Zhang J, Dunne R, Xiao A, Erdjument-Bromage H, Allis CD, Tempst P, Nimer SD

Genes & development.. 2008 March 122 (5):640-53. Epub 1900 01 01.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

During this visit, did this provider spend enough time with you?

5.0 stars

During this visit, did this provider show respect for what you had to say?

5.0 stars

During this visit did this provider give you easy to understand information about these health questions or concerns?

5.0 stars

During this visit, did this provider listen carefully to you?

5.0 stars

During this visit, did this provider explain things in a way that was easy to understand?

5.0 stars

Patient Comments

Doctor Dunne was on top of everything

Aug 24, 2024

Thoughtful and full information provided - at times after making sure I wanted to hear it.

Jul 27, 2024

5.0 stars

Very considerate providing a high level of care.

Jun 22, 2024

5.0 stars

They have been very good to me and for me

May 23, 2024

Dr. Dunne and his staff are extraordinary and my husband and I are so very grateful for their medical and emotional care. We drive 2 hours to get to Rochester and the University of Rochester hospital facility and the people there are so worth the drive.

Apr 10, 2024

5.0 stars

[...]. He is the best.

Feb 09, 2024

5.0 stars

Dr. Dunne had excellent plan to make sure there was nothing of concern on the Pet/CT [...] by doing another [...] to compare-- to see if the tiny suspicious area was gone [...]

Dec 01, 2023

5.0 stars

In all my years of going to do doctor I never had one who spent so much time to explain & answer all questions.

Oct 04, 2023

5.0 stars

All the persons in this office are very courteous and professional. I DON'T feel rushed.

Aug 14, 2023

5.0 stars

Providers imparts clear information, treats patient as a whole, listens to concerns

Aug 02, 2023

5.0

I feel very informed

Jun 30, 2023

5.0

Dr. Dunne has been my oncologist since the Fall of 2019. I feel he has given me the best care possible and I trust him. The care I received from him and other URMC doctors has been excellent.

Jun 16, 2023

5.0

Dr. Dunne is so thorough, kind, professional, and such an expert in his field. He is exceptional!

Jun 15, 2023

5.0

Dr. Dunne is fantastic

May 24, 2023

5.0

Again, very pleased with visit

Mar 30, 2023

5.0

Dr Dunne received notification that I had pneumonia show up on the day I had a CT scan taken as he was leaving the office. He called me and returned to his office in order to be able to write a prescription and get me started on antibiotics that evening. I was impressed with his concern for my well being!

Mar 17, 2023

5.0

Great culture drives great care!

Feb 23, 2023

5.0

Dr. Dunne is an excellent provider in all regards.

Feb 23, 2023

5.0

Dr. Dunne is very caring and explains things in a way that I can understand.

Feb 17, 2023

5.0

Dr. Dunne is OUTSTANDING!! Highly recommend him to anyone!!

Feb 16, 2023

5.0

Dr. Dunne is an exceptional health care provider. He is competent, compassionate, and caring. I am so glad that I am one of his patients.

Jul 30, 2022

5.0

No gripes!

Jul 28, 2022

5.0

The doctor always explains everything in a level I can understand.

Jun 21, 2022

5.0

I have already recommend Dr Richard Dunne to others.

Jun 06, 2022

5.0

I would recommend Dr. Dunne and staff to anyone.

Apr 20, 2022

No matter how big or small my issue may be they are always timely and caring in their response.

Feb 17, 2022